Scan lung tissue with a PET-CT during thoracic surgery
Part of Cancer, Lungs & breathing clinical trials.
This study tests whether a special imaging scan using a radioactive sugar (18F-FDG) can help doctors better examine lung cancer tissue during thoracic surgery. You may be offered the scan around the time of your operation to help researchers learn how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have suspected or confirmed lung cancer (lung malignancy)
- Your doctor plans thoracic surgery (surgery in the chest for your lung condition)
- You are able and willing to sign informed consent and follow the study plan
- Your blood sugar is not too high on surgery day (must be 200 mg/dL or less)
- You are able to have the planned thoracic surgery safely (no major surgery contraindications)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a specific analysis method (called FUR) can better measure how much “sugar” from PET scans is used by tumors. It uses regular PET/CT scans you may already get as part of standard care, and compares how the measurements work.
This study tests a high-resolution PET-CT scanner that takes pictures of tissue removed during surgery to help doctors see if all the cancer has been removed. You might qualify if you are having surgery for a range of cancers including breast, prostate, thyroid, skin, gastrointestinal, or brain tumors.
This trial uses a special PET-CT scanner to take high-resolution images of cancer tumors that have been surgically removed. The goal is to see how well these images match the results from standard lab tests, such as pathology, and to track long-term outcomes.
This trial tests a high-resolution PET-CT scan done during surgery to help surgeons see exactly where the cancer ends. It may help make sure all cancer is removed while saving healthy tissue.
This trial tests a newer PET/CT scan method to detect uncertain (indeterminate) lung nodules more accurately before biopsy or surgery. If you have a small lung nodule that doctors are still unsure about, this could help improve how nodules are found and assessed.
This trial tests a new PET scan dye (called 18F-Alfatide) that might help doctors see lung cancer and its spread more clearly before surgery. If it works, it could make sure surgery removes all the cancer.
Hear when a new Lung Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.